Overview
Availability
- Dr Mehrdad Pazhouhandeh is:
- Available for supervision
Qualifications
- Professional Doctorate of Pharmacy, Shahid Beheshti University of Medical Sciences
- Doctor of Philosophy of Basic and Applied Immunology, The University of Queensland
- Fellow, University of Queensland, University of Queensland
Works
Search Professor Mehrdad Pazhouhandeh’s works on UQ eSpace
2025
Journal Article
Neoself-antigen presentation in SLE: Mordred’s coronation in Arthur’s absence
Pazhouhandeh, Mehrdad, Sun, Hongjian and Yu, Di (2025). Neoself-antigen presentation in SLE: Mordred’s coronation in Arthur’s absence. Cell Research, 35 (8), 547-548. doi: 10.1038/s41422-024-01052-w
2024
Journal Article
Interferon disrupts immune and tissue homeostasis in SLE via CXCL13
Pazhouhandeh, Mehrdad and Yu, Di (2024). Interferon disrupts immune and tissue homeostasis in SLE via CXCL13. Nature Reviews Rheumatology, 20 (12), 745-746. doi: 10.1038/s41584-024-01164-y
2018
Journal Article
The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii
Irani, Nazanin, Basardeh, Eilnaz, Samiee, Fatemeh, Fateh, Abolfazl, Shooraj, Fahimeh, Rahimi, Ayoub, Shahcheraghi, Fereshteh, Vaziri, Farzam, Masoumi, Morteza, Pazhouhandeh, Mehrdad, Siadat, Seyed Davar, Kazemi-Lomedasht, Fatemeh and Jamnani, Fatemeh Rahimi (2018). The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii. Microbial Pathogenesis, 121, 310-317. doi: 10.1016/j.micpath.2018.05.051
2018
Journal Article
A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients
Pazhouhandeh, M., Sahraian, M. -A., Siadat, S. D., Fateh, A., Vaziri, F., Tabrizi, F., Ajorloo, F., Arshadi, A. K., Fatemi, E., Gavgani, S. Piri, Mahboudi, F. and Jamnani, F. Rahimi (2018). A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients. Clinical and Experimental Immunology, 192 (1), 18-32. doi: 10.1111/cei.13087
2017
Journal Article
Comparative network analysis of patients with non-small cell lung cancer and smokers for representing potential therapeutic targets
Pazhouhandeh, Mehrdad, Samiee, Fatemeh, Boniadi, Tahereh, Khedmat, Abbas Fadaei, Vahedi, Ensieh, Mirdamadi, Mahsa, Sigari, Naseh, Siadat, Seyed Davar, Vaziri, Farzam, Fateh, Abolfazl, Ajorloo, Faezeh, Tafsiri, Elham, Ghanei, Mostafa, Mahboudi, Fereidoun and Jamnani, Fatemeh Rahimi (2017). Comparative network analysis of patients with non-small cell lung cancer and smokers for representing potential therapeutic targets. Scientific Reports, 7 (1) 13812. doi: 10.1038/s41598-017-14195-1
2017
Journal Article
A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma
Ajorloo, Faezeh, Vaezi, Mohammad, Saadat, Alireza, Safaee, Seyed Reza, Gharib, Behrouz, Ghanei, Mostafa, Siadat, Seyed Davar, Vaziri, Farzam, Fateh, Abolfazl, Pazhouhandeh, Mehrdad, Vaziri, Behrouz, Moazemi, Reza, Mahboudi, Fereidoun and Jamnani, Fatemeh Rahimi (2017). A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. PLoS One, 12 (9), 1-25. doi: 10.1371/journal.pone.0183969
2015
Journal Article
Lipase immobilization onto polyethylenimine coated magnetic nanoparticles assisted by divalent metal chelated ions
Motevalizadeh, Seyed Farshad, Khoobi, Mehdi, Sadighi, Armin, Khalilvand-Sedagheh, Masoud, Pazhouhandeh, Mehrdad, Ramazani, Ali, Faramarzi, Mohammad Ali and Shafiee, Abbas (2015). Lipase immobilization onto polyethylenimine coated magnetic nanoparticles assisted by divalent metal chelated ions. Journal of Molecular Catalysis B: Enzymatic, 120, 75-83. doi: 10.1016/j.molcatb.2015.06.013
Supervision
Availability
- Dr Mehrdad Pazhouhandeh is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Dr Mehrdad Pazhouhandeh's areas of expertise, story ideas and help finding experts, contact our Media team: